Filter
1576
Filtered Results: 1576
Text search:
US
Pharmacist
Featured
Recommendations
125
New Publications
410
Language
Document type
No document type
832
Studies & Reports
334
Guidelines
193
Manuals
72
Strategic & Response Plan
58
Fact sheets
29
Training Material
23
Situation Updates
12
Resource Platforms
12
Brochures
6
Infographics
5
Countries / Regions
Global
70
India
67
Kenya
53
Ethiopia
49
South Africa
40
Liberia
37
Sierra Leone
35
Uganda
33
Nigeria
30
Western and Central Europe
28
Rwanda
27
Ghana
22
Africa
22
Zambia
21
Nepal
19
Bangladesh
19
Namibia
19
Syria
18
Tanzania
18
Ukraine
17
Malawi
17
Latin America and the Carribbean
13
Eastern Europe
13
Myanmar / Burma
13
Lesotho
12
Asia
12
Philippines
11
West and Central Africa
11
Zimbabwe
10
Cambodia
10
South–East Asia Region
10
Congo, Democratic Republic of
9
Botswana
9
Indonesia
9
Guinea
8
Germany
8
East and Southern Africa
8
Eswatini/ Swaziland
8
Cameroon
7
Haiti
7
Venezuela
7
South Sudan
7
Thailand
6
Burkina Faso
6
Mozambique
6
Russia
6
Vietnam
5
Brazil
5
Benin
4
Laos
4
Senegal
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Pakistan
4
Chile
3
Albania
3
Afghanistan
3
USA
3
Jordan
3
North America
3
United Kingdom
3
Papua New Guinea
3
Peru
2
Lithuania
2
Jamaica
2
Lebanon
2
Moldova
2
Sri Lanka
2
Georgia
2
Central African Republic
2
Mali
2
Iraq
2
Somalia
2
North Macedonia
1
Switzerland
1
Colombia
1
El Salvador
1
Turkey
1
China
1
Canada
1
Fiji
1
Estonia
1
Kyrgyzstan
1
Niger
1
Burundi
1
Qatar
1
Bulgaria
1
Hungary
1
Ireland
1
Western Pacific Region
1
Paraguay
1
Gabon
1
France
1
Portugal
1
Southern Africa
1
Bolivia
1
Argentina
1
Egypt
1
Sudan
1
Romania
1
Slovakia
1
Poland
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
607
Clinical Guidelines
118
Public Health
88
Key Resources
52
Women & Child Health
45
Pharmacy & Technologies
24
Capacity Building
21
Annual Report MEDBOX
2
Toolboxes
AMR
140
COVID-19
137
HIV
107
Pharmacy
104
Mental Health
101
TB
88
NCDs
45
Caregiver
42
Ebola
37
Rapid Response
36
Planetary Health
33
NTDs
29
Conflict
29
Global Health Education
29
Health Financing Toolbox
21
Refugee
17
Disability
16
Specific Hazards
7
Natural Hazards
5
Zika
5
Polio
5
Social Ethics
4
Cholera
2
Health Financing
1
A System of Health Accounts 2011: Revised Edition provides an updated and systematic description of the financial flows related to the consumption of health care goods and services. As demands for information increase and more countries implement and institutionalise health accounts according to the...
This paper has been prepared to inform discussion at the conference “Beating the DRUM - Domestic Resource Use and Mobilization for accelerating progress towards SDG3,”. Many countries face critical shortfalls in domestic resource use and mobilization (DRUM) for health, threatening to push health...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di...
Since the 1970s, voluntary contributions have become an increasingly important component of WHO's budget. As voluntary contributions tend to be earmarked for donor-specified programmes and projects, there are concerns that this trend has diverted focus away from WHO's strategic priorities, made coor...
This report analyses the intersection of HIV, COVID-19 and public debt in developing countries. The collision between COVID-19 and a crippling debt crisis have reversed decades of progress - putting present and future investments in health and HIV at risk. Pragmatic options to address the pandemic t...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
The development of this draft Proposed programme budget 2022–2023 comes at a unique moment for WHO. The world is in the grip of the coronavirus disease (COVID-19) pandemic and faces health, social and economic consequences on an unprecedented scale. Although it is not known when the COVID-19 pande...
This report examines the support to private healthcare provision in India by the World Bank’s private sector arm, the International Finance Corporation (IFC). Despite supporting private healthcare in the country since 1997, no healthcare results for lending and investments have been disclosed sinc...
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
This article analyzes the impact of the COVID-19 pandemic on foreign aid. Using examples from Canadian foreign aid, it argues that, despite the terrible toll it is exacting, the crisis has accelerated some significant positive pre-existing trends, both by destabilizing the perception of aid as flowi...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
This paper explores the angles and opportunities of digital health, with a look
at digital innovation and its potential to support patients with circulatory diseases.
In reviewing developments in the field, current applications as well as gaps, the paper aims to support policymakers in leveraging ...
ABSTRACT
More than 500 million people worldwide live with cardiovascular disease (CVD). Health systems today face fundamental challenges in delivering optimal care due to ageing populations, healthcare workforce constraints, financing, availability and affordability of CVD medicine, and service del...
